sur Theranexus (EPA:ALTHX)
Positive half-year results for Theranexus' liquidity contract
The biopharmaceutical company Theranexus has published the half-yearly report of its liquidity contract managed by Portzamparc, a BNP Paribas group company, as of June 30, 2026. The liquidity account shows 50,893 THX PHARMA shares and 112,290.14 euros.
In comparison, as of December 31, 2025, the account held 37,142 shares and €42,872.78. Since the contract came into effect in 2018, the number of shares and amounts has fluctuated, with a withdrawal of €50,000 in March 2025 and a deposit of €100,000 in February 2026.
During the first half of 2026, 221,783 shares were purchased for 708,161.86 euros and 208,032 shares were sold for 677,579.22 euros, illustrating dynamic market activity.
R. H.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Theranexus